OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery and Translational Research is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Intranasal drug delivery: opportunities and toxicologic challenges during drug development	245
Enhancement strategies for transdermal drug delivery systems: current trends and applications	208
Current hurdles to the translation of nanomedicines from bench to the clinic	119
Current approaches in lipid-based nanocarriers for oral drug delivery	102
Ultrasound-responsive polymer-based drug delivery systems	89
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine	80
Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress	73
Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems	72
Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system	70
Exosomal targeting and its potential clinical application	70
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system	62
Clinical translation of gold nanoparticles	62
Development of vaccine formulations: past, present, and future	52
Recent advances in porous microneedles: materials, fabrication, and transdermal applications	51
An overview of chitosan and its application in infectious diseases	51
Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems	49
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects	47
Intranasal drug delivery for treatment of Alzheimer’s disease	44
Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems	41
Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections	41
Nanotechnology-based approaches applied to nutraceuticals	39
Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs	38
Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery	38
Microneedle-based insulin transdermal delivery system: current status and translation challenges	36
Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies	35

Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases	35
Titanium dioxide nanotubes as drug carriers for infection control and osteogenesis of bone implants	35
Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases	34
Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery	33
Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles	32
Advances in 4D printing: from stimulation to simulation	32
Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide	32
Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations	32